Skip to content

Assessing the Efficacy of Kothanda Adangal (Varma Therapy) in Stress Management: An Open-Label Clinical Trial

EVALUATING THE THERAPEUTIC EFFECTS OF KOTHANDA ADANGAL (VARMA THERAPY) IN MANAGEMENT OF STRESS AN OPEN CLINICAL TRIAL - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090349
Enrollment
40
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders

Interventions

Intervention1: Varma thadaval: This study involves a Varmam therapy protocol using Kothanda Adangal to treat patients with stress-related symptoms. Before treatment, patients will provide informed con

Sponsors

Mangaleshwari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are having the symptoms of Headaches,Tense muscles, sore neck and back,Fatigue, Anxiety, worry, phobias, Insomnia, Irritability, Bouts of anger, Boredom, Depression , Binge eating, Constipation and Restlessness

Exclusion criteria

Exclusion criteria: patient who will meet any of the following criteria will be excluded from participation in this study: Severe mental health conditions: Patients with severe mental health conditions, such as psychosis, bipolar disorder, or suicidal ideation Chronic medical conditions: Patients with chronic medical conditions, such as diabetes, hypertension, or cardiovascular disease, that may interfere with the study Pregnancy or breastfeeding Current therapy: Patients who are currently receiving therapy or treatment for stress or anxiety Substance abuse: Patients with a history of substance abuse or addiction Contraindications to Kothanda Adangal: Patients with contraindications to Kothanda Adangal, such as bleeding disorders or pacemakers Inability to provide informed consent Coronary artery disease Tuberculosis Any other serious illness

Design outcomes

Primary

MeasureTime frame
Timepoint: 1. Baseline (before treatment) 2. Post-treatment (after 7 weeks of treatment) 3. Follow-up (2 months after treatment)

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI): The PSQI is a 19-item self-report questionnaire that assesses sleep quality & disturbances over a 1-month time interval. Timepoint: Baseline (before treatment) Post-treatment (after 7 weeks of treatment) Follow-up (2 months after treatment)

Countries

India

Contacts

Public ContactMangaleshwari

National Institute of Siddha

gj.christian.nis@gov.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026